| Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada: cardiovascular disease in COPD patients SM Curkendall, C DeLuise, JK Jones, S Lanes, MR Stang, E Goehring Jr, ... Annals of epidemiology 16 (1), 63-70, 2006 | 919 | 2006 |
| COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program S Sidney, M Sorel, CP Quesenberry Jr, C DeLuise, S Lanes, MD Eisner Chest 128 (4), 2068-2075, 2005 | 816 | 2005 |
| The reporting odds ratio and its advantages over the proportional reporting ratio KJ Rothman, S Lanes, ST Sacks Pharmacoepidemiology and drug safety 13 (8), 519-523, 2004 | 635 | 2004 |
| Ultrasound guidance decreases complications and improves the cost of care among patients undergoing thoracentesis and paracentesis CJ Mercaldi, SF Lanes Chest 143 (2), 532-538, 2013 | 371 | 2013 |
| A comprehensive hepatic safety analysis of nevirapine in different populations of HIV infected patients JO Stern, PA Robinson, J Love, S Lanes, MS Imperiale, DL Mayers JAIDS Journal of Acquired Immune Deficiency Syndromes 34, S21-S33, 2003 | 340 | 2003 |
| A metaregression analysis of the dose-response effect of aspirin on stroke ES Johnson, SF Lanes, CE Wentworth, MH Satterfield, BL Abebe, ... Archives of internal medicine 159 (11), 1248-1253, 1999 | 289 | 1999 |
| Resource utilization and cost of care for rheumatoid arthritis and osteoarthritis in a managed care setting. The importance of drug and surgery costs SF Lanes, LL Lanza, PW Radensky, RA Yood, RF Meenan, AM Walker, ... Arthritis & Rheumatism: Official Journal of the American College of …, 1997 | 228 | 1997 |
| Pooled clinical trial analysis of tiotropium safety S Kesten, M Jara, C Wentworth, S Lanes Chest 130 (6), 1695-1703, 2006 | 225 | 2006 |
| Burden of illness in idiopathic pulmonary fibrosis HR Collard, AJ Ward, S Lanes, D Cortney Hayflinger, DM Rosenberg, ... Journal of medical economics 15 (5), 829-835, 2012 | 207 | 2012 |
| A meta-analysis to assess the incidence of adverse effects associated with the transdermal nicotine patch S Greenland, MH Satterfield, SF Lanes Drug Safety 18 (4), 297-308, 1998 | 187 | 1998 |
| Guidelines for good pharmacoepidemiology practice (GPP) Public Policy Committee, International Society of Pharmacoepidemiology Pharmacoepidemiology and drug safety 25 (1), 2-10, 2016 | 172 | 2016 |
| The effect of adding ipratropium bromide to salbutamol in the treatment of acute asthma: a pooled analysis of three trials SF Lanes, JE Garrett, CE Wentworth III, JM Fitzgerald, JP Karpel Chest 114 (2), 365-372, 1998 | 165 | 1998 |
| Chronic obstructive pulmonary disease severity and cardiovascular outcomes SM Curkendall, S Lanes, C de Luise, MR Stang, JK Jones, D She, ... European journal of epidemiology 21, 803-813, 2006 | 164 | 2006 |
| Risk of serious upper gastrointestinal and cardiovascular thromboembolic complications with meloxicam G Singh, S Lanes, G Triadafilopoulos The American journal of medicine 117 (2), 100-106, 2004 | 162 | 2004 |
| Respiratory medications and risk of asthma death SF Lanes, LAG Rodriguez, C Huerta Thorax 57 (8), 683-686, 2002 | 143 | 2002 |
| Idiopathic pulmonary fibrosis in United States automated claims. Incidence, prevalence, and algorithm validation DB Esposito, S Lanes, M Donneyong, CN Holick, JA Lasky, D Lederer, ... American journal of respiratory and critical care medicine 192 (10), 1200-1207, 2015 | 141 | 2015 |
| Respiratory medications and the risk of cardiac arrhythmias C Huerta, SF Lanes, LAG Rodríguez Epidemiology 16 (3), 360-366, 2005 | 141 | 2005 |
| Oral contraceptive type and functional ovarian cysts SF Lanes, B Birmann, AM Walker, S Singer American journal of obstetrics and gynecology 166 (3), 956-961, 1992 | 133 | 1992 |
| Risk of severe life threatening asthma and beta agonist type: an example of confounding by severity. JE Garrett, SF Lanes, J Kolbe, HH Rea Thorax 51 (11), 1093-1099, 1996 | 87 | 1996 |
| Estimating effects from randomized trials with discontinuations: the need for intent-to-treat design and G-estimation S Greenland, S Lanes, M Jara Clinical Trials 5 (1), 5-13, 2008 | 77 | 2008 |
